» Articles » PMID: 37787774

The Susceptibility of Humans to Neurodegenerative and Neurodevelopmental Toxicities Caused by Organophosphorus Pesticides

Overview
Journal Arch Toxicol
Specialty Toxicology
Date 2023 Oct 3
PMID 37787774
Authors
Affiliations
Soon will be listed here.
Abstract

The toxicology field is concerned with the impact of organophosphorus (OP) compounds on human health. These compounds have been linked to an increased risk of neurological disorders, including neurodegenerative and neurodevelopmental diseases. This article aims to review studies on the role of OP compounds in developing these neurological disorders and explore how genetic variations can affect susceptibility to the neurotoxicity of these pesticides. Studies have shown that exposure to OP compounds can lead to the development of various neurological disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), attention deficit hyperactivity disorder (ADHD), autism, intellectual disability, and other developmental neurotoxicities. Apart from inhibiting the cholinesterase enzyme, OP compounds are believed to cause other pathological mechanisms at both the extracellular level (cholinergic, serotonergic, dopaminergic, glutamatergic, and GABAergic synapses) and the intracellular level (oxidative stress, mitochondrial dysfunction, inflammation, autophagy, and apoptosis) that contribute to these disorders. Specific genetic polymorphisms, including PON1, ABCB1, NOS, DRD4, GST, CYP, and APOE, have increased the risk of developing OP-related neurological disorders.

Citing Articles

Molecular interaction mechanisms on (-)-epigallocatechin-3-gallate improving activities of inhibited acetylcholinesterase by selected organophosphorus pesticides in vitro & vivo.

Wang L, Liu J, Gui W, Zhang R, Li X, Fang L Sci Rep. 2024; 14(1):22296.

PMID: 39333189 PMC: 11436701. DOI: 10.1038/s41598-024-72637-z.


Homocysteine Thiolactone Detoxifying Enzymes and Alzheimer's Disease.

Jakubowski H Int J Mol Sci. 2024; 25(15).

PMID: 39125665 PMC: 11312131. DOI: 10.3390/ijms25158095.


Association between organophosphorus insecticides exposure and osteoarthritis in patients with arteriosclerotic cardiovascular disease.

Zhu S, Zhou Y, Chao M, Zhang Y, Cheng W, Xu H BMC Public Health. 2024; 24(1):1873.

PMID: 39004719 PMC: 11247838. DOI: 10.1186/s12889-024-19414-9.


Old problems, new solutions: harnessing technology and innovation in Parkinson's disease-evidence and experiences from Thailand.

Bhidayasiri R J Neural Transm (Vienna). 2024; 131(6):721-738.

PMID: 38189972 DOI: 10.1007/s00702-023-02727-1.

References
1.
Abd El-Moneim Ibrahim K, Mohamed Abdelrahman S, Elhakim H, Ali Ragab E . Single or combined exposure to chlorpyrifos and cypermethrin provoke oxidative stress and downregulation in monoamine oxidase and acetylcholinesterase gene expression of the rat's brain. Environ Sci Pollut Res Int. 2020; 27(11):12692-12703. DOI: 10.1007/s11356-020-07864-8. View

2.
Abdollahi M, Mostafalou S, Pournourmohammadi S, Shadnia S . Oxidative stress and cholinesterase inhibition in saliva and plasma of rats following subchronic exposure to malathion. Comp Biochem Physiol C Toxicol Pharmacol. 2004; 137(1):29-34. DOI: 10.1016/j.cca.2003.11.002. View

3.
Abdollahi M, Moridani M, Aruoma O, Mostafalou S . Oxidative stress in aging. Oxid Med Cell Longev. 2014; 2014:876834. PMC: 3997972. DOI: 10.1155/2014/876834. View

4.
Alugubelly N, Mohammed A, Carr R . Persistent proteomic changes in glutamatergic and GABAergic signaling in the amygdala of adolescent rats exposed to chlorpyrifos as juveniles. Neurotoxicology. 2021; 85:234-244. PMC: 8276847. DOI: 10.1016/j.neuro.2021.05.012. View

5.
Amiri S, Shekari Khaniani M, Mohammadi A, Asadian M, Fanid L, Shafiee-Kandjani A . Molecular Evaluation of Ex3 VNTR Polymorphism of the DRD4 Gene in Patients With Autism Spectrum Disorder. Iran J Child Neurol. 2022; 16(4):23-31. PMC: 9699926. DOI: 10.22037/ijcn.v16i4.34289. View